Global Medical Director, Respiratory

Global Medical Director, Respiratory Locations:  GSK HQ UK, New Oxford Street or USA PA - Upper Providence Reporting to : VP, Global Medical Lead - Respiratory   The CPO organisation partners closely with R&D and Commercial to translate cutting-edge science into measurable health outcomes, grounded in the patient voice and external insights from healthcare systems and decision-makers worldwide. Joining CPO means working across the full product lifecycle and collaborating with diverse expert teams – from Patients & External Environment and Medical Planning to Data Generation, Scientific Communications, Medical Impact, Proactive Risk Ownership and Integrated Evidence Strategy – to ensure robust evidence, clear medical insight and responsible risk ownership shape strategy and execution at scale. It’s a highly visible, purpose-driven environment where your expertise can directly influence how innovative therapies are developed, communicated and used to improve lives around the world.   The Global Medical Director role is a unique opportunity for an experienced, innovative, and proactive medical professional to facilitate the understanding of the value of our medicines and vaccines, the science behind them and the public impact they can offer. This is accomplished by developing and implementing the global medical scientific strategic plan to generate insights, shape optimal care through scientific dialogue and education and delivering impact by generating and communicating the evidence and delivering solutions to close the gaps.   The Global Medical Director for a specific asset will work in a thriving team of medical business leaders where people will be inspired to drive towards achieving our goals of getting Ahead of Disease Together and positively impacting patient and population health outcomes globally by using innovation even more competitively to help close gaps in medical care.   Key Responsibilities include, but are not limited to:     • Support the Global Medical Portfolio and Asset Strategy Leads in the development and timely execution of practice changing Global Medical Affairs Plans (MAP) and Integrated Evidence plans (IEP) in partnership with key stakeholders through the GMAT and IET. • Thinks globally, while deeply understands priority LOC (Local Operating Company) needs and success measures.  This is accomplished through extensive partnership and collaboration with LOC teams to understand landscape, market value drivers, unmet medical needs and timelines for deliverables required for their success. • Partners across the internal ecosystem and with external partners to deliver Medical Plans that prioritize external impact above all else on time and on budget. • Leveraging insights and learnings, inputs into the design of clinical trials and development plans to optimize the positive impact for patients. • Drives excellence in scientific engagement by developing a strong collaborative network of global external experts (HCPs, patients, payors and regulators) to be engaged in advice seeking activities and appropriate initiatives to advance clinical care and patient outcomes in partnership with the LOC Medical teams where those experts reside. • Ensures colleagues have a robust knowledge of the relevant and emerging clinical evidence, supporting their training by partnering on the creation and delivery of high-quality scientific materials for both internal and external use. • Partner with Global Product Strategy, Market Access, and core country teams to support/advise on core claims and material review. • Ensure appropriate medical governance oversight including management of product-related issues with potential impact on patient safety and of risk assessment and mitigation plan associated with deliverables/stra